Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM PAR $0.0001
-
Total 13F shares
-
9,424,193
-
Share change
-
+1,039,444
-
Total reported value
-
$38,450,630
-
Put/Call ratio
-
4109%
-
Price per share
-
$4.08
-
Number of holders
-
28
-
Value change
-
+$1,688,190
-
Number of buys
-
20
-
Number of sells
-
13
Institutional Holders of OXYGEN BIOTHERAPEUTICS INC - COM PAR $0.0001 (OXBT) as of Q2 2014
As of 30 Jun 2014,
OXYGEN BIOTHERAPEUTICS INC - COM PAR $0.0001 (OXBT) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,424,193 shares.
The largest 10 holders included
SABBY MANAGEMENT, LLC, GREAT POINT PARTNERS LLC, Broadfin Capital, LLC, BANK OF AMERICA CORP /DE/, Pine River Capital Management L.P., RA CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Bank of New York Mellon Corp, D. E. Shaw & Co., Inc., and DEERFIELD MANAGEMENT CO.
This page lists
28
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.